Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
Amyotrophic Lateral Sclerosis (ALS) belongs to the family of neurodegenerative disorders and is classified as fronto-temporal dementia (FTD), progressive muscular atrophy, primary lateral sclerosis, and pseudobulbar palsy. Even though endocrine dysfunction independently impacts the ALS-related survi...
Guardado en:
Autores principales: | Alexios-Fotios A. Mentis, Anastasia M. Bougea, George P. Chrousos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e15cc60d549476cb898c0639cb47e88 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis
por: Polina S. Goncharova, et al.
Publicado: (2021) -
Amyotrophic lateral sclerosis and other motor neuron disorders official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
Publicado: (2005) -
A Platform to Understand Amyotrophic Lateral Sclerosis (ALS) and Extend Human Motor Neurons Longevity
por: Cáceres,D. E, et al.
Publicado: (2019)